S.No. |
Compound |
Reference |
Inhibited |
Physicochemical Properties and Toxicity Risks |
1 |
Kolaviron | Iwu et al., 2011 | Aldose reductase |
Properties and Risk Assessment |
2 |
Scopoletin | Kim et al., 2013 | Aldose reductase |
Properties and Risk Assessment |
3 |
Gossypol | Deck et al., 1999 | Aldose reductase |
Properties and Risk Assessment |
4 |
Citronellol | Jagdale et al., 2015 | Aldose reductase |
Properties and Risk Assessment |
5 |
Miglitol(Known Drug) | Sels et al., 1999 | Alpha-glucosidase |
Properties and Risk Assessment |
6 |
Acarbose(Known Drug) | Martin and Montgomery, 1996 | Alpha-glucosidase |
Properties and Risk Assessment |
7 |
Luteolin-7-O-glucoside | Kim et al., 2000 | Alpha-glucosidase |
Properties and Risk Assessment |
8 |
Luteolin | Kim et al., 2000 | Alpha-glucosidase |
Properties and Risk Assessment |
9 |
Amentoflavone | Kim et al., 2000 | Alpha-glucosidase |
Properties and Risk Assessment |
10 |
Diadzein | Kim et al., 2000 | Alpha-glucosidase |
Properties and Risk Assessment |
11 |
Caffeic acid | Oboh et al., 2015 | Alpha-glucosidase |
Properties and Risk Assessment |
12 |
Lupeol | Siddique and Saleem, 2011 | Alpha-glucosidase |
Properties and Risk Assessment |
13 |
Diphlorethohydroxy-carmalol | Heo et al., 2009 | Alpha-glucosidase |
Properties and Risk Assessment |
14 |
Alpha-Homonojirimycin | Kim et al., 1999 | Alpha-glucosidase |
Properties and Risk Assessment |
15 |
Daucosterol | Asghari et al., 2015 | Alpha-glucosidase |
Properties and Risk Assessment |
16 |
Berberin | Yin et al., 2012 | Alpha-glucosidase |
Properties and Risk Assessment |
17 |
Salacinol | Morikawa et al., 2015 | Alpha-glucosidase |
Properties and Risk Assessment |
18 |
2,5-Dihydroxymethyl-3,4-Dihydroxypyrrolidine | Carreiro et al., 2014 | Alpha-glucosidase |
Properties and Risk Assessment |
19 |
Kotalanol | Xie et al., 2011 | Alpha-glucosidase |
Properties and Risk Assessment |
20 |
Neoponkoranol | Xie et al., 2011 | Alpha-glucosidase |
Properties and Risk Assessment |
21 |
Neosalaprinol | Xie et al., 2011 | Alpha-glucosidase |
Properties and Risk Assessment |
22 |
Nummularine-R | Choudhary et al., 2011 | Alpha-glucosidase |
Properties and Risk Assessment |
23 |
Nummularin-C | Choudhary et al., 2011 | Alpha-glucosidase |
Properties and Risk Assessment |
24 |
Hemsine-A | Choudhary et al., 2011 | Alpha-glucosidase |
Properties and Risk Assessment |
25 |
Iriflophenone 2-O-a-L-rhamnopyranoside | Feng et al., 2011 | Alpha-glucosidase |
Properties and Risk Assessment |
26 |
2,4,6-tribromophenol | Kim et al., 2011 | Alpha-glucosidase |
Properties and Risk Assessment |
27 |
2,4-dibromophenol | Kim et al., 2011 | Alpha-glucosidase |
Properties and Risk Assessment |
28 |
Procyanidin | Schafer and Hogger, 2007 | Alpha-glucosidase |
Properties and Risk Assessment |
29 |
Serotonin | Takahashi and Miyazawa, 2012 | Alpha-glucosidase |
Properties and Risk Assessment |
30 |
Butyl-isobutyl-phthalate | Bu et al., 2010 | Alpha-glucosidase |
Properties and Risk Assessment |
31 |
Aloeresin A | Jong-Anurakkun et al., 2008 | Alpha-glucosidase |
Properties and Risk Assessment |
32 |
Miglitol(Known Drug) | Reuser and Wisselaar, 1994 | Alpha-glucosidase |
Properties and Risk Assessment |
33 |
Acarbose(Known Drug) | Goldstein and Muller-Wieland, 2008 | Alpha-glucosidase |
Properties and Risk Assessment |
34 |
Hydnocarpin | Reddy et al., 2013 | Alpha-glucosidase |
Properties and Risk Assessment |
35 |
Vasicine | Gao et al., 2007 | Alpha-glucosidase |
Properties and Risk Assessment |
36 |
Vasicinol | Gao et al., 2007 | Alpha-glucosidase |
Properties and Risk Assessment |
37 |
Myricetin | Kang et al., 2015 | Alpha-glucosidase |
Properties and Risk Assessment |
38 |
Diosgenin | Ghosh et al., 2014 | Alpha-glucosidase |
Properties and Risk Assessment |
39 |
Quercetin | Li et al., 2009 | Alpha-glucosidase |
Properties and Risk Assessment |
40 |
Turmeric | Lekshmi et al., 2012 | Alpha-glucosidase |
Properties and Risk Assessment |
41 |
(2S)-Euchrenone a7 | Yang et al., 2012 | Alpha-glucosidase |
Properties and Risk Assessment |
42 |
Chalcomoracin | Yang et al., 2012 | Alpha-glucosidase |
Properties and Risk Assessment |
43 |
Moracin C | Yang et al., 2012 | Alpha-glucosidase |
Properties and Risk Assessment |
44 |
Moracin D | Yang et al., 2012 | Alpha-glucosidase |
Properties and Risk Assessment |
45 |
Moracin N | Yang et al., 2012 | Alpha-glucosidase |
Properties and Risk Assessment |
46 |
5-O-caffeoylquinic acid | Ishikawa et al., 2007 | Alpha-glucosidase |
Properties and Risk Assessment |
47 |
Chebulagic acid | Pham et al., 2014 | Alpha-glucosidase |
Properties and Risk Assessment |
48 |
Narcissin | Pham et al., 2014 | Alpha-glucosidase |
Properties and Risk Assessment |
49 |
Corilagin | Pham et al., 2014 Honma et al., 2010 | Alpha-glucosidase |
Properties and Risk Assessment |
50 |
Macatannin B | Maria et al., 2010 | Alpha-glucosidase |
Properties and Risk Assessment |
51 |
Mallotinic acid | Maria et al., 2010 | Alpha-glucosidase |
Properties and Risk Assessment |
52 |
Cyanidin-3-galactoside | Adisakwattana et al., 2009 Akkarachiyasit et al., 2010 | Alpha-glucosidase |
Properties and Risk Assessment |
53 |
Luteolin-7-O-glucoside | Kim et al., 2000 | Amylase |
Properties and Risk Assessment |
54 |
Luteolin | Kim et al., 2000 | Amylase |
Properties and Risk Assessment |
55 |
Amentoflavone | Kim et al., 2000 | Amylase |
Properties and Risk Assessment |
56 |
Diadzein | Kim et al., 2000 | Amylase |
Properties and Risk Assessment |
57 |
Ellagic acid | Pinto et al., 2010 | Amylase |
Properties and Risk Assessment |
58 |
Caffeic acid | Oboh et al., 2015 | Amylase |
Properties and Risk Assessment |
59 |
Diphlorethohydroxy-carmalol | Heo et al., 2009 | Amylase |
Properties and Risk Assessment |
60 |
Gallic acid | Gunawan-Puteri et al., 2012 | Amylase |
Properties and Risk Assessment |
61 |
Mahanimbine | Dineshkumar et al., 2010 | Amylase |
Properties and Risk Assessment |
62 |
Acarbose(Known Drug) | Goldstein and Muller-Wieland, 2008 | Amylase |
Properties and Risk Assessment |
63 |
Fukugetin | Yunfang et al., 2014 | Amylase |
Properties and Risk Assessment |
64 |
Diosgenin | Ghosh et al., 2014 | Amylase |
Properties and Risk Assessment |
65 |
Turmeric | Lekshmi et al., 2012 | Amylase |
Properties and Risk Assessment |
66 |
Corilagin | Gunawan-Puteri et al., 2012 | Amylase |
Properties and Risk Assessment |
67 |
Macatannin B | Gunawan-Puteri et al., 2012 | Amylase |
Properties and Risk Assessment |
68 |
Cyanidin-3-galactoside | Akkarachiyasit et al., 2010 | Amylase |
Properties and Risk Assessment |
69 |
Castanospermine | Rhinehart et al., 1987 Robinson et al., 1989 | Glycohydrolase |
Properties and Risk Assessment |
70 |
Diosgenin | McAnuff-Harding et al., 2006 | Lactase |
Properties and Risk Assessment |
71 |
Miglitol(Known Drug) | Goldstein and Muller-Wieland, 2008 | Maltase |
Properties and Risk Assessment |
72 |
Diosgenin | McAnuff-Harding et al., 2006 | Maltase |
Properties and Risk Assessment |
73 |
Castanospermine | Rhinehart et al., 1987 Robinson et al., 1989 | Sucrase |
Properties and Risk Assessment |
74 |
Vasicine | Gao et al., 2007 | Sucrase |
Properties and Risk Assessment |
75 |
Vasicinol | Gao et al., 2007 | Sucrase |
Properties and Risk Assessment |
76 |
Miglitol(Known Drug) | Goldstein and Muller-Wieland, 2008 | Sucrase |
Properties and Risk Assessment |